Defect Closure in the Lipomatous Hypertrophied Atrial Septum With the Amplatzer Muscular Ventricular Septal Defect Closure Device: A Case Series

被引：8

作者：

Lin, C. Huie ^{[1
]}

Balzer, David T. ^{[2
]}

Lasala, John M. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Internal Med, Div Cardiol, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Dept Pediat, Div Cardiol, St Louis, MO 63110 USA

来源：

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS | 2011年 / 78卷 / 01期

关键词：

atrial septal defect; patent foramen ovale closure; lipomatous hypertrophy of the atrial septum; muscular ventricular septal defect device; stroke; transesophageal echocardiography; PATENT FORAMEN OVALE; INTERATRIAL SEPTUM; PATIENT; RISK;

D O I：

10.1002/ccd.22858

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Variations in the anatomy of the atrial septum can confound the transcatheter closure of atrial septal defects and patent foramen ovale. While lipomatous hypertrophy of the atrial septum is not frequently encountered, attempts to use standard atrial septal occlusion devices in such patient can lead to malapposition and continued shunt. Some operators have suggested that atrial septal hypertrophy is a relative contraindication to transcatheter-based closure techniques. We present a novel technique exploiting the features of the Amplatzer muscular ventricular septal defect occluder to treat atrial septal defects in the setting of lipomatous hypertrophy of the atrial septum in two patients. (C) 2011 Wiley-Liss, Inc.

引用

页码：102 / 107

页数：6

共 13 条

[1] Lipomatous hypertrophy of the inter-atrial septum and stroke [J].

Abboud, H ;

Brochet, E ;

Amarenco, P .

CEREBROVASCULAR DISEASES, 2004, 18 (02) :178-178

[2]

Al-Faleh H, 2005, CAN J CARDIOL, V21, P789

[3] Erosion of amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk [J].

Amin, Z ;

Hijazi, ZM ;

Bass, JL ;

Cheatham, JP ;

Hellenbrand, WE ;

Kleinman, CS .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 63 (04) :496-502

[4] LIPOMATOUS HYPERTROPHY OF THE CARDIAC INTERATRIAL SEPTUM - AN UNUSUAL COMPLICATION IN LONG-TERM HOME PARENTERAL-NUTRITION IN ADULT PATIENTS [J].

BEAU, P ;

MICHEL, P ;

COISNE, D ;

MORICHAUBEAUCHANT, M .

JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1991, 15 (06) :659-662

[5] Lipomatous hypertrophy of the interatrial septum and upper right atrial inflow obstruction [J].

Breuer, M ;

Wippermann, J ;

Franke, U ;

Wahlers, T .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 22 (06) :1023-1025

[6] Lipomatous hypertrophy of the interatrial septum - A prospective study of incidence, imaging findings, and clinical symptoms [J].

Heyer, CM ;

Kagel, T ;

Lemburg, SP ;

Bauer, TT ;

Nicolas, V .

CHEST, 2003, 124 (06) :2068-2073

[7]

Lopez-Candales Angel, 2002, Am J Geriatr Cardiol, V11, P399, DOI 10.1111/j.1076-7460.2002.01629.x

[8] Atrial septal defect device closure in a patient with lipomatous hypertrophy of the atrial septum [J].

Moir, WS ;

McGaw, DJ ;

Harper, RW ;

Gelman, J .

CIRCULATION, 2003, 107 (24) :E217-E217

[9]

Rao Peter M, 2009, Circ Cardiovasc Imaging, V2, pe25, DOI 10.1161/CIRCIMAGING.108.818435

[10] Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series [J].

Rigatelli, Gianluca ;

Dell'Avvocata, Fabio ;

Giordan, Massimo ;

Ronco, Federico ;

Braggion, Gabriele ;

Schenal, Nella ;

Aggio, Silvio ;

Cardaioli, Paolo .

JOURNAL OF CARDIOVASCULAR MEDICINE, 2010, 11 (02) :91-95

← 1 2 →